← Back to Search

Young Adults' Reactions to Low Nicotine Cigarette Advertising (YLA Trial)

N/A
Waitlist Available
Led By Andrew Strasser, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0
Awards & highlights
No Placebo-Only Group

Summary

This trial studies how advertising low-nicotine cigarettes affects young adults' perceptions and behaviors. It involves both smokers and non-smokers to see if these cigarettes can help reduce addiction. The findings could inform public health policies on cigarette marketing.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Attention
Perceived health risks
Recall
+1 more
Secondary study objectives
Attitudes
Purchasing behavior

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: SmokersExperimental Treatment2 Interventions
Smokers will be randomized to view an advertisement with either true or misleading and implicit or explicit harm messaging content.
Group II: Non-smokersExperimental Treatment2 Interventions
Non-smokers will be randomized to view an advertisement with either true or misleading and implicit or explicit harm messaging content.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,082 Previous Clinical Trials
42,727,274 Total Patients Enrolled
15 Trials studying Smoking
8,247 Patients Enrolled for Smoking
Abramson Cancer Center of the University of PennsylvaniaLead Sponsor
359 Previous Clinical Trials
108,429 Total Patients Enrolled
4 Trials studying Smoking
417 Patients Enrolled for Smoking
National Cancer Institute (NCI)NIH
13,938 Previous Clinical Trials
41,023,132 Total Patients Enrolled
68 Trials studying Smoking
59,548 Patients Enrolled for Smoking
Abramson Cancer Center at Penn MedicineLead Sponsor
418 Previous Clinical Trials
464,796 Total Patients Enrolled
8 Trials studying Smoking
3,958 Patients Enrolled for Smoking
Andrew Strasser, PhDPrincipal InvestigatorUniversity of Pennsylvania
3 Previous Clinical Trials
452 Total Patients Enrolled
2 Trials studying Smoking
404 Patients Enrolled for Smoking
Melissa Mercincavage, PhDPrincipal Investigator - University of Pennsylvania
University of Pennsylvania
1 Previous Clinical Trials
1 Trials studying Smoking
~12 spots leftby Dec 2025